FDA Inspection
Camco Chemical CompanyCamco Chemical Company – FDA Inspection, Mar 2, 2022
Record Details
This FDA Inspection record concerns Camco Chemical Company, with an inspection on March 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Camco Chemical Company
- Inspection Date
- March 2, 2022
- Product Type
- Drugs
View Company Profile
ID · d5abd2fa-b143-41c7-bb0b-d3d50044179f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163474
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.68(b)Backup file not maintained
- 21 CFR 211.67(c)Cleaning/maintenance records not kept
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Camco Chemical Company
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Camco Chemical Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.